#2609 Comparison of baseline patient characteristics of the CONVINCE randomized controlled trial with existing trial and registry populations

Tom Yuen(Fresenius Kabi (China)), Krister Cromm(Humboldt-Universität zu Berlin), Giovanni Strippoli(The University of Sydney), Jennifer Braun(Fresenius Medical Care (Germany)), Kakiu Ho(Fresenius Kabi (China)), Ngoc Minh Pham(Fresenius Medical Care (Germany)), Manuela Stauss‐Grabo(Fresenius Medical Care (Germany))
Nephrology Dialysis Transplantation
May 1, 2024
10.1093/ndt/gfae069.838
Cited by 0

Related Papers

Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure
|New England Journal of Medicine|2023|287
Neurocognitive and Educational Outcomes in Children and Adolescents with CKD
|Clinical Journal of the American Society of Nephrology|2018|138
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
|BMJ Open|2020|67
Haemodiafiltration versus haemodialysis for kidney failure: an individual patient data meta-analysis of randomised controlled trials
|The Lancet|2024|50
The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration
|Kidney International|2024|48